BOSTON ONCOLOGY

Serial Number 97684330
Registration 7258910
700

Registration Progress

Application Filed
Nov 18, 2022
Under Examination
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered
Jan 2, 2024

Trademark Image

BOSTON ONCOLOGY

Basic Information

Serial Number
97684330
Registration Number
7258910
Filing Date
November 18, 2022
Registration Date
January 2, 2024
Published for Opposition
October 17, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 2, 2024
Registration
Registered
Classes
042

Rights Holder

Boston Oncology, LLC

16
Address
245 First Street, Suite 1800
Cambridge, MA 02142

Ownership History

Boston Oncology, LLC

Original Applicant
16
Cambridge, MA

Boston Oncology, LLC

Original Applicant
16
Cambridge, MA

Boston Oncology, LLC

Owner at Publication
16
Cambridge, MA

Boston Oncology, LLC

Owner at Publication
16
Cambridge, MA

Boston Oncology, LLC

Original Registrant
16
Cambridge, MA

Boston Oncology, LLC

Original Registrant
16
Cambridge, MA

Legal Representation

Attorney
Garfield Goodrum

Application History

30 events
Date Code Type Description Documents
Jan 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 9, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 9, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 9, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 9, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 9, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 11, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jul 11, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Dec 10, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 10, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 24, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Nov 24, 2022 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Nov 24, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Nov 24, 2022 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Nov 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...
Nov 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
First Use Anywhere: Aug 31, 2021
First Use in Commerce: Aug 31, 2021

Additional Information

Design Mark
The mark consists of a logo comprised of 4 circles, one larger than the other 3 and the 3 drawn on the circumference of the larger at the upper- and lower-right quadrants and the lower-left quadrant, positioned to the left of the terms BOSTON ONCOLOGY.
Design Mark
The mark consists of a logo comprised of 4 circles, one larger than the other 3 and the 3 drawn on the circumference of the larger at the upper- and lower-right quadrants and the lower-left quadrant, positioned to the left of the terms BOSTON ONCOLOGY.
Color Claim
Color is not claimed as a feature of the mark.
Color Claim
Color is not claimed as a feature of the mark.
Other
BOSTON ONCOLOGY has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
Other
BOSTON ONCOLOGY has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.

Classification

International Classes
042